Harel Adrian 4/A
4/A · BRAINSTORM CELL THERAPEUTICS INC. · Filed Aug 27, 2012
Insider Transaction Report
Form 4/AAmended
Harel Adrian
Acting Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2012-08-01+70,000→ 70,000 totalExercise: $0.26From: 2013-08-01Exp: 2022-08-01→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]Options vests in twelve (12) consecutive, equal monthly installments commencing on September 1, 2012 until fully vested on August 1, 2013.
- [F2]On August 3, 2012, a Form 4 was filed to report stock options granted on August 1, 2012 by Issuer to Reporting Person. This amendment is being filed to report a corrected vesting schedule, described above.